fanta.bio Sample: CNhs11981
22921 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1246 / 16563 (7.5%) | 401 / 165630 (0.2%) | −324.0 | −324.0 | 31.07 |
| TP53 SRX19538274 | U2OS Bone | 454 / 16563 (2.7%) | 158 / 165630 (0.1%) | −324.0 | −324.0 | 28.73 |
| HIF1A SRX11007095 | HK-2 Kidney | 2427 / 16563 (14.7%) | 847 / 165630 (0.5%) | −324.0 | −324.0 | 28.65 |
| TP53 SRX19538268 | U2OS Bone | 451 / 16563 (2.7%) | 167 / 165630 (0.1%) | −324.0 | −324.0 | 27.01 |
| TP53 SRX19538276 | U2OS Bone | 454 / 16563 (2.7%) | 169 / 165630 (0.1%) | −324.0 | −324.0 | 26.86 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1866 / 16563 (11.3%) | 715 / 165630 (0.4%) | −324.0 | −324.0 | 26.10 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1835 / 16563 (11.1%) | 715 / 165630 (0.4%) | −324.0 | −324.0 | 25.66 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2620 / 16563 (15.8%) | 1080 / 165630 (0.7%) | −324.0 | −324.0 | 24.26 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2530 / 16563 (15.3%) | 1063 / 165630 (0.6%) | −324.0 | −324.0 | 23.80 |
| SCML2 SRX644728 | 293 Kidney | 1531 / 16563 (9.2%) | 688 / 165630 (0.4%) | −324.0 | −324.0 | 22.25 |
| HIF1A SRX20663235 | HK-2 Kidney | 526 / 16563 (3.2%) | 238 / 165630 (0.1%) | −324.0 | −324.0 | 22.10 |
| TP53 SRX19538279 | Osteoblasts Bone | 548 / 16563 (3.3%) | 258 / 165630 (0.2%) | −324.0 | −324.0 | 21.24 |
| FOXP1 SRX736067 | LNCAP Prostate | 2171 / 16563 (13.1%) | 1034 / 165630 (0.6%) | −324.0 | −324.0 | 21.00 |
| MYH11 SRX265221 | ME-1 Blood | 909 / 16563 (5.5%) | 590 / 165630 (0.4%) | −324.0 | −324.0 | 15.41 |
| BRD4 SRX9419935 | BT-474 Breast | 3883 / 16563 (23.4%) | 2672 / 165630 (1.6%) | −324.0 | −324.0 | 14.53 |
| MED1 SRX9419945 | BT-474 Breast | 3870 / 16563 (23.4%) | 2700 / 165630 (1.6%) | −324.0 | −324.0 | 14.33 |
| MED1 SRX9419944 | BT-474 Breast | 3779 / 16563 (22.8%) | 2686 / 165630 (1.6%) | −324.0 | −324.0 | 14.07 |
| BRD4 SRX9419937 | BT-474 Breast | 3851 / 16563 (23.3%) | 2747 / 165630 (1.7%) | −324.0 | −324.0 | 14.02 |
| BRD4 SRX9419936 | BT-474 Breast | 3920 / 16563 (23.7%) | 2831 / 165630 (1.7%) | −324.0 | −324.0 | 13.85 |
| MED1 SRX9419946 | BT-474 Breast | 3942 / 16563 (23.8%) | 2849 / 165630 (1.7%) | −324.0 | −324.0 | 13.84 |
| BRD4 SRX9419938 | BT-474 Breast | 3910 / 16563 (23.6%) | 2834 / 165630 (1.7%) | −324.0 | −324.0 | 13.80 |
| MED1 SRX9419947 | BT-474 Breast | 3810 / 16563 (23.0%) | 2805 / 165630 (1.7%) | −324.0 | −324.0 | 13.58 |
| EZH2 SRX2146136 | LNCAP Prostate | 8671 / 16563 (52.4%) | 7691 / 165630 (4.6%) | −324.0 | −324.0 | 11.27 |
| BRD4 SRX736201 | 90-8TL Neural | 6439 / 16563 (38.9%) | 6419 / 165630 (3.9%) | −324.0 | −324.0 | 10.03 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 829 / 16563 (5.0%) | 888 / 165630 (0.5%) | −324.0 | −324.0 | 9.34 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1930 / 16563 (11.7%) | 2602 / 165630 (1.6%) | −324.0 | −324.0 | 7.42 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1473 / 16563 (8.9%) | 3598 / 165630 (2.2%) | −324.0 | −324.0 | 4.09 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1715 / 16563 (10.4%) | 4929 / 165630 (3.0%) | −324.0 | −324.0 | 3.48 |
| AGO2 SRX4708039 | Hep G2 Liver | 2128 / 16563 (12.8%) | 7234 / 165630 (4.4%) | −324.0 | −324.0 | 2.94 |
| PBX4 SRX2731658 | PC-3 Prostate | 815 / 16563 (4.9%) | 26009 / 165630 (15.7%) | −324.0 | −324.0 | 0.31 |
| 5-mC SRX882970 | LNCAP Prostate | 3178 / 16563 (19.2%) | 14764 / 165630 (8.9%) | −323.0 | −320.0 | 2.15 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 738 / 16563 (4.5%) | 908 / 165630 (0.5%) | −321.2 | −318.2 | 8.13 |
| FOS SRX150477 | MCF 10A Breast | 541 / 16563 (3.3%) | 19464 / 165630 (11.8%) | −316.1 | −313.1 | 0.28 |
| RUNX1 SRX2513054 | 293 Kidney | 3474 / 16563 (21.0%) | 17206 / 165630 (10.4%) | −308.9 | −305.9 | 2.02 |
| 5-mC SRX882968 | LNCAP Prostate | 3106 / 16563 (18.8%) | 14651 / 165630 (8.8%) | −304.2 | −301.2 | 2.12 |
| FOS SRX150478 | MCF 10A Breast | 596 / 16563 (3.6%) | 19926 / 165630 (12.0%) | −301.4 | −298.4 | 0.30 |
| FOXA1 SRX4815198 | MCF-7 Breast | 852 / 16563 (5.1%) | 23884 / 165630 (14.4%) | −299.0 | −296.1 | 0.36 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 510 / 16563 (3.1%) | 18335 / 165630 (11.1%) | −296.2 | −293.2 | 0.28 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 607 / 16563 (3.7%) | 615 / 165630 (0.4%) | −294.9 | −292.0 | 9.87 |
| Epitope tags SRX10549776 | K-562 Blood | 1579 / 16563 (9.5%) | 5016 / 165630 (3.0%) | −291.9 | −289.0 | 3.15 |
| FOXA1 SRX4815197 | MCF-7 Breast | 593 / 16563 (3.6%) | 19574 / 165630 (11.8%) | −291.6 | −288.7 | 0.30 |
| TP53 SRX19538280 | Osteoblasts Bone | 430 / 16563 (2.6%) | 197 / 165630 (0.1%) | −289.9 | −287.0 | 21.83 |
| FOXA1 SRX176862 | MCF-7 Breast | 264 / 16563 (1.6%) | 13659 / 165630 (8.2%) | −288.7 | −285.8 | 0.19 |
| YAP1 SRX757325 | H2052 Lung | 636 / 16563 (3.8%) | 20158 / 165630 (12.2%) | −287.9 | −285.0 | 0.32 |
| TP53 SRX19538267 | U2OS Bone | 402 / 16563 (2.4%) | 151 / 165630 (0.1%) | −287.3 | −284.4 | 26.62 |
| TP53 SRX19538273 | U2OS Bone | 397 / 16563 (2.4%) | 144 / 165630 (0.1%) | −286.4 | −283.6 | 27.57 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 434 / 16563 (2.6%) | 214 / 165630 (0.1%) | −285.8 | −283.0 | 20.28 |
| TP53 SRX19538281 | Osteoblasts Bone | 463 / 16563 (2.8%) | 282 / 165630 (0.2%) | −283.0 | −280.1 | 16.42 |
| FOXA1 SRX176863 | MCF-7 Breast | 247 / 16563 (1.5%) | 13031 / 165630 (7.9%) | −278.2 | −275.4 | 0.19 |
| ESR1 SRX7624157 | MCF-7 Breast | 668 / 16563 (4.0%) | 20248 / 165630 (12.2%) | −274.7 | −271.9 | 0.33 |
| TP53 SRX19538275 | U2OS Bone | 396 / 16563 (2.4%) | 168 / 165630 (0.1%) | −273.3 | −270.5 | 23.57 |
| 5-mC SRX882965 | LNCAP Prostate | 2551 / 16563 (15.4%) | 11488 / 165630 (6.9%) | −270.0 | −267.2 | 2.22 |
| FOXA1 SRX3931044 | MCF-7 Breast | 546 / 16563 (3.3%) | 18040 / 165630 (10.9%) | −267.0 | −264.3 | 0.30 |
| YAP1 SRX757326 | H2052 Lung | 548 / 16563 (3.3%) | 17984 / 165630 (10.9%) | −264.3 | −261.5 | 0.30 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 584 / 16563 (3.5%) | 677 / 165630 (0.4%) | −262.9 | −260.1 | 8.63 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2225 / 16563 (13.4%) | 9437 / 165630 (5.7%) | −262.4 | −259.7 | 2.36 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 649 / 16563 (3.9%) | 910 / 165630 (0.5%) | −259.2 | −256.4 | 7.13 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 260 / 16563 (1.6%) | 12708 / 165630 (7.7%) | −257.6 | −254.9 | 0.20 |
| BRD1 SRX286203 | RKO Digestive tract | 1313 / 16563 (7.9%) | 4009 / 165630 (2.4%) | −254.1 | −251.3 | 3.28 |
| ESR1 SRX4367193 | MCF-7 Breast | 921 / 16563 (5.6%) | 23378 / 165630 (14.1%) | −253.8 | −251.0 | 0.39 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 266 / 16563 (1.6%) | 12706 / 165630 (7.7%) | −253.5 | −250.8 | 0.21 |
| FOXA1 SRX1161177 | MCF-7 Breast | 219 / 16563 (1.3%) | 11775 / 165630 (7.1%) | −253.2 | −250.4 | 0.19 |
| FOS SRX4192880 | MCF 10A Breast | 443 / 16563 (2.7%) | 15817 / 165630 (9.5%) | −251.1 | −248.4 | 0.28 |
| IRF3 SRX11453858 | Hep G2 Liver | 318 / 16563 (1.9%) | 83 / 165630 (0.1%) | −248.2 | −245.5 | 38.31 |
| FOXA1 SRX371483 | MCF-7 Breast | 265 / 16563 (1.6%) | 12532 / 165630 (7.6%) | −248.2 | −245.5 | 0.21 |
| KAT7 SRX101303 | RKO Digestive tract | 1473 / 16563 (8.9%) | 4985 / 165630 (3.0%) | −248.0 | −245.3 | 2.95 |
| TP53 SRX19538269 | U2OS Bone | 483 / 16563 (2.9%) | 440 / 165630 (0.3%) | −247.7 | −245.0 | 10.98 |
| ESR1 SRX371478 | MCF-7 Breast | 317 / 16563 (1.9%) | 13441 / 165630 (8.1%) | −245.9 | −243.3 | 0.24 |
| ESR1 SRX7624156 | MCF-7 Breast | 414 / 16563 (2.5%) | 15129 / 165630 (9.1%) | −244.8 | −242.1 | 0.27 |
| GATA3 SRX190239 | MCF-7 Breast | 375 / 16563 (2.3%) | 14436 / 165630 (8.7%) | −244.5 | −241.8 | 0.26 |
| ESR1 SRX371469 | MCF-7 Breast | 243 / 16563 (1.5%) | 11999 / 165630 (7.2%) | −244.4 | −241.7 | 0.20 |
| FOXA1 SRX371482 | MCF-7 Breast | 372 / 16563 (2.2%) | 14374 / 165630 (8.7%) | −244.2 | −241.5 | 0.26 |
| AGO2 SRX6783958 | Hep G2 Liver | 1335 / 16563 (8.1%) | 4256 / 165630 (2.6%) | −243.8 | −241.2 | 3.14 |
| ESR1 SRX20282961 | MCF-7 Breast | 319 / 16563 (1.9%) | 13331 / 165630 (8.0%) | −241.0 | −238.3 | 0.24 |
| TP53 SRX19538270 | U2OS Bone | 464 / 16563 (2.8%) | 419 / 165630 (0.3%) | −238.9 | −236.3 | 11.07 |
| CIC SRX13262055 | Astrocytes Neural | 3111 / 16563 (18.8%) | 16251 / 165630 (9.8%) | −237.9 | −235.2 | 1.91 |
| AGO2 SRX6783957 | Hep G2 Liver | 1340 / 16563 (8.1%) | 4381 / 165630 (2.6%) | −236.3 | −233.6 | 3.06 |
| FOXA1 SRX371481 | MCF-7 Breast | 260 / 16563 (1.6%) | 12094 / 165630 (7.3%) | −236.2 | −233.6 | 0.21 |
| FOS SRX150517 | MCF 10A Breast | 467 / 16563 (2.8%) | 15716 / 165630 (9.5%) | −234.8 | −232.2 | 0.30 |
| AR SRX1067071 | LHSAR Prostate | 555 / 16563 (3.4%) | 17086 / 165630 (10.3%) | −232.8 | −230.2 | 0.32 |
| BRPF3 SRX796085 | RKO Digestive tract | 1164 / 16563 (7.0%) | 3471 / 165630 (2.1%) | −231.4 | −228.8 | 3.35 |
| FOXA1 SRX1161173 | MCF-7 Breast | 178 / 16563 (1.1%) | 10322 / 165630 (6.2%) | −231.1 | −228.5 | 0.17 |
| TLE3 SRX4815191 | MCF-7 Breast | 233 / 16563 (1.4%) | 11402 / 165630 (6.9%) | −230.1 | −227.5 | 0.20 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 382 / 16563 (2.3%) | 14112 / 165630 (8.5%) | −229.8 | −227.2 | 0.27 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 388 / 16563 (2.3%) | 14214 / 165630 (8.6%) | −229.7 | −227.1 | 0.27 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 176 / 16563 (1.1%) | 10223 / 165630 (6.2%) | −228.9 | −226.3 | 0.17 |
| BRPF3 SRX796084 | RKO Digestive tract | 1594 / 16563 (9.6%) | 5990 / 165630 (3.6%) | −228.5 | −225.9 | 2.66 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 474 / 16563 (2.9%) | 15608 / 165630 (9.4%) | −227.9 | −225.3 | 0.30 |
| JUNB SRX8488088 | SUM 229PE Breast | 546 / 16563 (3.3%) | 16779 / 165630 (10.1%) | −227.8 | −225.2 | 0.33 |
| ESR1 SRX176860 | MCF-7 Breast | 461 / 16563 (2.8%) | 15380 / 165630 (9.3%) | −227.4 | −224.8 | 0.30 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 329 / 16563 (2.0%) | 13074 / 165630 (7.9%) | −226.4 | −223.9 | 0.25 |
| FOXA1 SRX1161176 | MCF-7 Breast | 237 / 16563 (1.4%) | 11333 / 165630 (6.8%) | −225.2 | −222.6 | 0.21 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 629 / 16563 (3.8%) | 17993 / 165630 (10.9%) | −225.0 | −222.5 | 0.35 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 238 / 16563 (1.4%) | 11345 / 165630 (6.8%) | −224.9 | −222.4 | 0.21 |
| ESR1 SRX20282960 | MCF-7 Breast | 304 / 16563 (1.8%) | 12563 / 165630 (7.6%) | −224.4 | −221.8 | 0.24 |
| ESR1 SRX371476 | MCF-7 Breast | 168 / 16563 (1.0%) | 9919 / 165630 (6.0%) | −224.0 | −221.5 | 0.17 |
| ESR1 SRX176861 | MCF-7 Breast | 464 / 16563 (2.8%) | 15317 / 165630 (9.2%) | −224.0 | −221.4 | 0.30 |
| FOXA1 SRX1161175 | MCF-7 Breast | 169 / 16563 (1.0%) | 9924 / 165630 (6.0%) | −223.4 | −220.8 | 0.17 |
| TP53 SRX19538282 | Osteoblasts Bone | 398 / 16563 (2.4%) | 304 / 165630 (0.2%) | −221.6 | −219.1 | 13.09 |
| AR SRX1067070 | LHSAR Prostate | 736 / 16563 (4.4%) | 19504 / 165630 (11.8%) | −221.4 | −218.9 | 0.38 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 351 / 16563 (2.1%) | 13277 / 165630 (8.0%) | −220.3 | −217.7 | 0.26 |
| ESR1 SRX371471 | ZR-75-1 Breast | 289 / 16563 (1.7%) | 12138 / 165630 (7.3%) | −219.3 | −216.8 | 0.24 |
| IRF3 SRX11453861 | Hep G2 Liver | 287 / 16563 (1.7%) | 84 / 165630 (0.1%) | −218.4 | −215.9 | 34.17 |
| YAP1 SRX5718140 | 293 Kidney | 485 / 16563 (2.9%) | 15476 / 165630 (9.3%) | −218.2 | −215.7 | 0.31 |
| FOXA1 SRX100454 | T-47D Breast | 366 / 16563 (2.2%) | 13389 / 165630 (8.1%) | −215.4 | −212.9 | 0.27 |
| ESR1 SRX371479 | MCF-7 Breast | 242 / 16563 (1.5%) | 11146 / 165630 (6.7%) | −215.4 | −212.9 | 0.22 |
| BRPF3 SRX796086 | RKO Digestive tract | 1508 / 16563 (9.1%) | 5672 / 165630 (3.4%) | −215.3 | −212.8 | 2.66 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 473 / 16563 (2.9%) | 15143 / 165630 (9.1%) | −213.9 | −211.4 | 0.31 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 229 / 16563 (1.4%) | 10842 / 165630 (6.5%) | −213.4 | −210.9 | 0.21 |
| FOS SRX150476 | MCF 10A Breast | 512 / 16563 (3.1%) | 15747 / 165630 (9.5%) | −213.0 | −210.5 | 0.33 |
| ESR1 SRX371470 | ZR-75-1 Breast | 239 / 16563 (1.4%) | 10991 / 165630 (6.6%) | −212.0 | −209.6 | 0.22 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 239 / 16563 (1.4%) | 10987 / 165630 (6.6%) | −211.9 | −209.4 | 0.22 |
| ESR1 SRX371467 | MCF-7 Breast | 291 / 16563 (1.8%) | 11950 / 165630 (7.2%) | −211.8 | −209.3 | 0.24 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 235 / 16563 (1.4%) | 10905 / 165630 (6.6%) | −211.6 | −209.1 | 0.22 |
| SMARCA2 SRX8119677 | MeT-5A Others | 477 / 16563 (2.9%) | 15131 / 165630 (9.1%) | −211.5 | −209.0 | 0.32 |
| FOXA1 SRX3923514 | MCF-7 Breast | 267 / 16563 (1.6%) | 11488 / 165630 (6.9%) | −211.0 | −208.5 | 0.23 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 262 / 16563 (1.6%) | 11387 / 165630 (6.9%) | −210.8 | −208.3 | 0.23 |
| ESR1 SRX1531791 | MCF-7 Breast | 263 / 16563 (1.6%) | 11390 / 165630 (6.9%) | −210.2 | −207.8 | 0.23 |
| FOXA1 SRX11222441 | MCF-7 Breast | 185 / 16563 (1.1%) | 9878 / 165630 (6.0%) | −210.1 | −207.6 | 0.19 |
| ESR1 SRX20282939 | MCF-7 Breast | 327 / 16563 (2.0%) | 12544 / 165630 (7.6%) | −210.1 | −207.6 | 0.26 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 362 / 16563 (2.2%) | 13155 / 165630 (7.9%) | −210.0 | −207.5 | 0.28 |
| ING5 SRX286202 | RKO Digestive tract | 1392 / 16563 (8.4%) | 5055 / 165630 (3.1%) | −209.7 | −207.3 | 2.75 |
| FOXA1 SRX371480 | MCF-7 Breast | 161 / 16563 (1.0%) | 9371 / 165630 (5.7%) | −209.6 | −207.1 | 0.17 |
| CEBPB SRX150632 | HeLa Uterus | 699 / 16563 (4.2%) | 18508 / 165630 (11.2%) | −208.8 | −206.4 | 0.38 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1068 / 16563 (6.4%) | 23758 / 165630 (14.3%) | −207.0 | −204.6 | 0.45 |
| AR SRX1067066 | LHSAR Prostate | 644 / 16563 (3.9%) | 17579 / 165630 (10.6%) | −206.2 | −203.8 | 0.37 |
| ESR1 SRX371468 | MCF-7 Breast | 156 / 16563 (0.9%) | 9153 / 165630 (5.5%) | −205.4 | −203.0 | 0.17 |
| FOXA1 SRX1787653 | MCF-7 Breast | 209 / 16563 (1.3%) | 10219 / 165630 (6.2%) | −205.3 | −202.9 | 0.20 |
| ESR1 SRX194569 | MCF-7 Breast | 301 / 16563 (1.8%) | 11901 / 165630 (7.2%) | −204.2 | −201.8 | 0.25 |
| TP53 SRX19538271 | U2OS Bone | 643 / 16563 (3.9%) | 1222 / 165630 (0.7%) | −203.4 | −201.0 | 5.26 |
| GATA3 SRX5057632 | MCF-7 Breast | 159 / 16563 (1.0%) | 9155 / 165630 (5.5%) | −203.2 | −200.8 | 0.17 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 204 / 16563 (1.2%) | 10035 / 165630 (6.1%) | −202.3 | −199.9 | 0.20 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1775 / 16563 (10.7%) | 7598 / 165630 (4.6%) | −202.1 | −199.7 | 2.34 |
| ESR1 SRX20282954 | MCF-7 Breast | 318 / 16563 (1.9%) | 12132 / 165630 (7.3%) | −201.9 | −199.5 | 0.26 |
| ARID1A SRX5089376 | MCF-7 Breast | 230 / 16563 (1.4%) | 10521 / 165630 (6.4%) | −201.7 | −199.3 | 0.22 |
| TEAD1 SRX3401272 | MCF-7 Breast | 193 / 16563 (1.2%) | 9783 / 165630 (5.9%) | −201.2 | −198.8 | 0.20 |
| TP53 SRX396254 | Fibroblasts Others | 946 / 16563 (5.7%) | 2666 / 165630 (1.6%) | −200.8 | −198.4 | 3.55 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1411 / 16563 (8.5%) | 5314 / 165630 (3.2%) | −200.4 | −198.0 | 2.66 |
| FOXA1 SRX11222442 | MCF-7 Breast | 162 / 16563 (1.0%) | 9125 / 165630 (5.5%) | −199.9 | −197.5 | 0.18 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 180 / 16563 (1.1%) | 9476 / 165630 (5.7%) | −199.3 | −196.9 | 0.19 |
| FOXA1 SRX11222437 | MCF-7 Breast | 182 / 16563 (1.1%) | 9511 / 165630 (5.7%) | −199.3 | −196.9 | 0.19 |
| KAT6A SRX20971022 | Fibroblasts Others | 264 / 16563 (1.6%) | 81 / 165630 (0.0%) | −198.7 | −196.3 | 32.59 |
| AR SRX10820653 | LNCAP Prostate | 330 / 16563 (2.0%) | 209 / 165630 (0.1%) | −198.6 | −196.2 | 15.79 |
| FOXA1 SRX1161174 | MCF-7 Breast | 294 / 16563 (1.8%) | 11587 / 165630 (7.0%) | −198.1 | −195.7 | 0.25 |
| ESR1 SRX194572 | MCF-7 Breast | 164 / 16563 (1.0%) | 9106 / 165630 (5.5%) | −197.8 | −195.5 | 0.18 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 262 / 16563 (1.6%) | 11001 / 165630 (6.6%) | −197.8 | −195.4 | 0.24 |
| TRP47 SRX4548329 | THP-1 Blood | 2617 / 16563 (15.8%) | 13623 / 165630 (8.2%) | −197.6 | −195.2 | 1.92 |
| RAC1 SRX10365541 | MCF-7 Breast | 125 / 16563 (0.8%) | 8244 / 165630 (5.0%) | −196.5 | −194.1 | 0.15 |
| GATA3 SRX176864 | MCF-7 Breast | 200 / 16563 (1.2%) | 9747 / 165630 (5.9%) | −195.0 | −192.7 | 0.21 |
| ESR1 SRX20282972 | MCF-7 Breast | 337 / 16563 (2.0%) | 12244 / 165630 (7.4%) | −194.8 | −192.4 | 0.28 |
| ESR1 SRX10365535 | MCF-7 Breast | 229 / 16563 (1.4%) | 10261 / 165630 (6.2%) | −193.6 | −191.2 | 0.22 |
| RAC1 SRX10365543 | MCF-7 Breast | 129 / 16563 (0.8%) | 8245 / 165630 (5.0%) | −193.3 | −191.0 | 0.16 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 266 / 16563 (1.6%) | 10933 / 165630 (6.6%) | −193.1 | −190.8 | 0.24 |
| AR SRX1067067 | LHSAR Prostate | 533 / 16563 (3.2%) | 15408 / 165630 (9.3%) | −193.1 | −190.7 | 0.35 |
| TLE3 SRX4815192 | MCF-7 Breast | 255 / 16563 (1.5%) | 10721 / 165630 (6.5%) | −192.8 | −190.5 | 0.24 |
| FOXA1 SRX3931055 | MCF-7 Breast | 233 / 16563 (1.4%) | 10305 / 165630 (6.2%) | −192.6 | −190.3 | 0.23 |
| FOXA1 SRX3931043 | MCF-7 Breast | 294 / 16563 (1.8%) | 11417 / 165630 (6.9%) | −192.5 | −190.2 | 0.26 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 258 / 16563 (1.6%) | 10763 / 165630 (6.5%) | −192.4 | −190.1 | 0.24 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1096 / 16563 (6.6%) | 23568 / 165630 (14.2%) | −192.4 | −190.1 | 0.47 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 243 / 16563 (1.5%) | 10479 / 165630 (6.3%) | −192.1 | −189.8 | 0.23 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 318 / 16563 (1.9%) | 11820 / 165630 (7.1%) | −191.7 | −189.4 | 0.27 |
| AR SRX9469988 | LAPC-4 Prostate | 405 / 16563 (2.4%) | 13286 / 165630 (8.0%) | −191.2 | −188.9 | 0.30 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 315 / 16563 (1.9%) | 11745 / 165630 (7.1%) | −191.1 | −188.8 | 0.27 |
| ESR1 SRX371477 | MCF-7 Breast | 116 / 16563 (0.7%) | 7899 / 165630 (4.8%) | −191.0 | −188.7 | 0.15 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 788 / 16563 (4.8%) | 19173 / 165630 (11.6%) | −190.9 | −188.6 | 0.41 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 644 / 16563 (3.9%) | 1317 / 165630 (0.8%) | −190.8 | −188.5 | 4.89 |
| FOS SRX4192879 | MCF 10A Breast | 352 / 16563 (2.1%) | 12355 / 165630 (7.5%) | −190.1 | −187.8 | 0.28 |
| FOXA1 SRX3931054 | MCF-7 Breast | 269 / 16563 (1.6%) | 10894 / 165630 (6.6%) | −190.0 | −187.7 | 0.25 |
| GATA3 SRX190194 | SK-N-SH Neural | 775 / 16563 (4.7%) | 18949 / 165630 (11.4%) | −190.0 | −187.7 | 0.41 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1195 / 16563 (7.2%) | 24815 / 165630 (15.0%) | −189.9 | −187.6 | 0.48 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 259 / 16563 (1.6%) | 10677 / 165630 (6.4%) | −188.8 | −186.6 | 0.24 |
| ESR1 SRX10365536 | MCF-7 Breast | 136 / 16563 (0.8%) | 8262 / 165630 (5.0%) | −188.5 | −186.2 | 0.16 |
| ESR1 SRX20282955 | MCF-7 Breast | 325 / 16563 (2.0%) | 11787 / 165630 (7.1%) | −186.8 | −184.5 | 0.28 |
| FOXA1 SRX028634 | MCF-7 Breast | 119 / 16563 (0.7%) | 7837 / 165630 (4.7%) | −186.4 | −184.1 | 0.15 |
| ESR1 SRX371475 | BT-474 Breast | 125 / 16563 (0.8%) | 7969 / 165630 (4.8%) | −186.3 | −184.1 | 0.16 |
| FOXA1 SRX100506 | Hep G2 Liver | 420 / 16563 (2.5%) | 13362 / 165630 (8.1%) | −186.1 | −183.8 | 0.31 |
| ESR1 SRX371474 | BT-474 Breast | 112 / 16563 (0.7%) | 7654 / 165630 (4.6%) | −185.4 | −183.1 | 0.15 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 560 / 16563 (3.4%) | 15558 / 165630 (9.4%) | −185.2 | −182.9 | 0.36 |
| VGLL1 SRX24602130 | BT-20 Breast | 317 / 16563 (1.9%) | 11587 / 165630 (7.0%) | −185.0 | −182.7 | 0.27 |
| LEO1 SRX1873456 | SEM Blood | 1472 / 16563 (8.9%) | 5958 / 165630 (3.6%) | −184.6 | −182.3 | 2.47 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 234 / 16563 (1.4%) | 10065 / 165630 (6.1%) | −183.9 | −181.7 | 0.23 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 267 / 16563 (1.6%) | 114 / 165630 (0.1%) | −183.9 | −181.7 | 23.42 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 655 / 16563 (4.0%) | 1419 / 165630 (0.9%) | −183.9 | −181.6 | 4.62 |
| ESR1 SRX2943591 | MCF-7 Breast | 199 / 16563 (1.2%) | 9400 / 165630 (5.7%) | −183.9 | −181.6 | 0.21 |
| ESR1 SRX4367192 | MCF-7 Breast | 673 / 16563 (4.1%) | 17211 / 165630 (10.4%) | −183.4 | −181.2 | 0.39 |
| JUNB SRX8488073 | SUM 229PE Breast | 614 / 16563 (3.7%) | 16307 / 165630 (9.8%) | −182.9 | −180.7 | 0.38 |
| FOXA1 SRX3923516 | MCF-7 Breast | 201 / 16563 (1.2%) | 9408 / 165630 (5.7%) | −182.8 | −180.5 | 0.21 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 275 / 16563 (1.7%) | 10771 / 165630 (6.5%) | −182.4 | −180.2 | 0.26 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 267 / 16563 (1.6%) | 10614 / 165630 (6.4%) | −182.0 | −179.7 | 0.25 |
| BRD4 SRX736204 | 90-8TL Neural | 929 / 16563 (5.6%) | 2796 / 165630 (1.7%) | −181.4 | −179.2 | 3.32 |
| GATA3 SRX6712581 | MCF-7 Breast | 243 / 16563 (1.5%) | 10149 / 165630 (6.1%) | −181.1 | −178.9 | 0.24 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 289 / 16563 (1.7%) | 10969 / 165630 (6.6%) | −180.8 | −178.5 | 0.26 |
| FOXA1 SRX1787652 | MCF-7 Breast | 165 / 16563 (1.0%) | 8640 / 165630 (5.2%) | −180.7 | −178.4 | 0.19 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1147 / 16563 (6.9%) | 4033 / 165630 (2.4%) | −180.5 | −178.3 | 2.84 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1307 / 16563 (7.9%) | 25914 / 165630 (15.6%) | −180.5 | −178.3 | 0.50 |
| ESR1 SRX20282973 | MCF-7 Breast | 389 / 16563 (2.3%) | 12650 / 165630 (7.6%) | −179.9 | −177.7 | 0.31 |
| FOXA1 SRX1787655 | MCF-7 Breast | 127 / 16563 (0.8%) | 7828 / 165630 (4.7%) | −179.7 | −177.5 | 0.16 |
| FOXA1 SRX1161203 | T-47D Breast | 208 / 16563 (1.3%) | 9451 / 165630 (5.7%) | −179.6 | −177.4 | 0.22 |
| EP300 SRX150579 | HeLa Uterus | 189 / 16563 (1.1%) | 9082 / 165630 (5.5%) | −179.6 | −177.4 | 0.21 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 819 / 16563 (4.9%) | 2244 / 165630 (1.4%) | −179.4 | −177.1 | 3.65 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 798 / 16563 (4.8%) | 18885 / 165630 (11.4%) | −179.3 | −177.0 | 0.42 |
| FOXA2 SRX100448 | Hep G2 Liver | 350 / 16563 (2.1%) | 11974 / 165630 (7.2%) | −179.2 | −177.0 | 0.29 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 412 / 16563 (2.5%) | 13000 / 165630 (7.8%) | −179.1 | −176.9 | 0.32 |
| MITF SRX1555436 | 501A Epidermis | 1943 / 16563 (11.7%) | 9228 / 165630 (5.6%) | −178.8 | −176.6 | 2.11 |
| ESR1 SRX2881000 | MCF-7 Breast | 266 / 16563 (1.6%) | 10495 / 165630 (6.3%) | −178.7 | −176.5 | 0.25 |
| ARID1A SRX5089379 | MCF-7 Breast | 307 / 16563 (1.9%) | 11207 / 165630 (6.8%) | −178.3 | −176.1 | 0.27 |
| STAT3 SRX2020842 | HCC70 Breast | 591 / 16563 (3.6%) | 15786 / 165630 (9.5%) | −178.2 | −176.0 | 0.37 |
| MEAF6 DRX234811 | 293 Kidney | 1672 / 16563 (10.1%) | 7391 / 165630 (4.5%) | −177.9 | −175.7 | 2.26 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 904 / 16563 (5.5%) | 20301 / 165630 (12.3%) | −177.0 | −174.8 | 0.45 |
| FOXA2 SRX3230382 | Hep G2 Liver | 445 / 16563 (2.7%) | 13462 / 165630 (8.1%) | −176.9 | −174.7 | 0.33 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 795 / 16563 (4.8%) | 18747 / 165630 (11.3%) | −176.9 | −174.7 | 0.42 |
| FOXA1 SRX1787651 | MCF-7 Breast | 156 / 16563 (0.9%) | 8350 / 165630 (5.0%) | −176.9 | −174.7 | 0.19 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 243 / 16563 (1.5%) | 10008 / 165630 (6.0%) | −176.4 | −174.2 | 0.24 |
| FOXA1 SRX5323843 | MCF-7 Breast | 136 / 16563 (0.8%) | 7914 / 165630 (4.8%) | −176.1 | −173.9 | 0.17 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 289 / 16563 (1.7%) | 10815 / 165630 (6.5%) | −175.9 | −173.7 | 0.27 |
| FOXA1 SRX15430999 | T-47D Breast | 354 / 16563 (2.1%) | 11917 / 165630 (7.2%) | −175.3 | −173.1 | 0.30 |
| ESR1 SRX2881002 | MCF-7 Breast | 296 / 16563 (1.8%) | 10912 / 165630 (6.6%) | −175.1 | −172.9 | 0.27 |
| FOXA1 SRX3923517 | MCF-7 Breast | 209 / 16563 (1.3%) | 9330 / 165630 (5.6%) | −174.9 | −172.7 | 0.22 |
| MEAF6 DRX300417 | 293 Kidney | 1540 / 16563 (9.3%) | 6577 / 165630 (4.0%) | −174.8 | −172.7 | 2.34 |
| Epitope tags DRX443510 | 293 Kidney | 1462 / 16563 (8.8%) | 6068 / 165630 (3.7%) | −174.8 | −172.7 | 2.41 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1032 / 16563 (6.2%) | 21971 / 165630 (13.3%) | −174.4 | −172.3 | 0.47 |
| PGR SRX1012655 | MCF-7 Breast | 186 / 16563 (1.1%) | 8876 / 165630 (5.4%) | −174.4 | −172.2 | 0.21 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 132 / 16563 (0.8%) | 7787 / 165630 (4.7%) | −174.4 | −172.2 | 0.17 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1873 / 16563 (11.3%) | 8843 / 165630 (5.3%) | −174.1 | −171.9 | 2.12 |
| FOXA1 SRX11222438 | MCF-7 Breast | 149 / 16563 (0.9%) | 8111 / 165630 (4.9%) | −173.5 | −171.3 | 0.18 |
| ESR1 SRX20282940 | MCF-7 Breast | 359 / 16563 (2.2%) | 11935 / 165630 (7.2%) | −173.3 | −171.2 | 0.30 |
| FOXA1 SRX1447317 | MCF-7 Breast | 187 / 16563 (1.1%) | 8859 / 165630 (5.3%) | −173.2 | −171.1 | 0.21 |
| BMI1 SRX7196721 | SF8628 Neural | 1692 / 16563 (10.2%) | 7623 / 165630 (4.6%) | −173.2 | −171.0 | 2.22 |
| ESR1 SRX8537722 | MCF-7 Breast | 291 / 16563 (1.8%) | 10763 / 165630 (6.5%) | −173.1 | −171.0 | 0.27 |
| Epitope tags SRX10549778 | K-562 Blood | 1128 / 16563 (6.8%) | 4044 / 165630 (2.4%) | −172.1 | −170.0 | 2.79 |
| CEBPA SRX2630241 | Hep G2 Liver | 403 / 16563 (2.4%) | 12618 / 165630 (7.6%) | −172.0 | −169.9 | 0.32 |
| SREBF2 SRX5359048 | HCC70 Breast | 1665 / 16563 (10.1%) | 7465 / 165630 (4.5%) | −171.9 | −169.7 | 2.23 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1781 / 16563 (10.8%) | 8261 / 165630 (5.0%) | −171.7 | −169.6 | 2.16 |
| WWTR1 SRX10119367 | MCF 10A Breast | 388 / 16563 (2.3%) | 12364 / 165630 (7.5%) | −171.7 | −169.5 | 0.31 |
| FOXA1 SRX190181 | A549 Lung | 213 / 16563 (1.3%) | 9306 / 165630 (5.6%) | −171.7 | −169.5 | 0.23 |
| EP300 SRX2194266 | SUM 159PT Breast | 586 / 16563 (3.5%) | 15472 / 165630 (9.3%) | −171.6 | −169.4 | 0.38 |
| ESR1 SRX10365532 | MCF-7 Breast | 156 / 16563 (0.9%) | 8190 / 165630 (4.9%) | −171.3 | −169.2 | 0.19 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1704 / 16563 (10.3%) | 7744 / 165630 (4.7%) | −171.3 | −169.2 | 2.20 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 732 / 16563 (4.4%) | 17618 / 165630 (10.6%) | −171.0 | −168.9 | 0.42 |
| FOXA1 SRX3931033 | MCF-7 Breast | 187 / 16563 (1.1%) | 8791 / 165630 (5.3%) | −170.9 | −168.8 | 0.21 |
| AR SRX10820651 | LNCAP Prostate | 340 / 16563 (2.1%) | 323 / 165630 (0.2%) | −170.6 | −168.4 | 10.53 |
| FOXA1 SRX028635 | MCF-7 Breast | 140 / 16563 (0.8%) | 7838 / 165630 (4.7%) | −170.4 | −168.3 | 0.18 |
| FOXA1 SRX3923518 | MCF-7 Breast | 205 / 16563 (1.2%) | 9118 / 165630 (5.5%) | −170.4 | −168.2 | 0.22 |
| NR2F2 SRX190293 | MCF-7 Breast | 348 / 16563 (2.1%) | 11620 / 165630 (7.0%) | −169.3 | −167.2 | 0.30 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1606 / 16563 (9.7%) | 7130 / 165630 (4.3%) | −169.0 | −166.9 | 2.25 |
| EP300 SRX176885 | MCF-7 Breast | 147 / 16563 (0.9%) | 7940 / 165630 (4.8%) | −169.0 | −166.9 | 0.19 |
| JUN SRX4192884 | MCF 10A Breast | 271 / 16563 (1.6%) | 10277 / 165630 (6.2%) | −168.8 | −166.6 | 0.26 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 204 / 16563 (1.2%) | 9041 / 165630 (5.5%) | −168.5 | −166.3 | 0.23 |
| NR3C1 SRX17639412 | A549 Lung | 365 / 16563 (2.2%) | 11872 / 165630 (7.2%) | −168.3 | −166.2 | 0.31 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1116 / 16563 (6.7%) | 22853 / 165630 (13.8%) | −168.1 | −166.0 | 0.49 |
| SS18 SRX3468047 | Fibroblasts Others | 883 / 16563 (5.3%) | 19657 / 165630 (11.9%) | −168.1 | −166.0 | 0.45 |
| FOXA1 SRX100477 | Hep G2 Liver | 383 / 16563 (2.3%) | 12160 / 165630 (7.3%) | −168.1 | −166.0 | 0.31 |
| ESR1 SRX330067 | MCF-7 Breast | 297 / 16563 (1.8%) | 10708 / 165630 (6.5%) | −168.0 | −165.9 | 0.28 |
| FOXA1 SRX5323829 | T-47D Breast | 164 / 16563 (1.0%) | 8237 / 165630 (5.0%) | −167.4 | −165.3 | 0.20 |
| ESR1 SRX4451213 | MCF-7 Breast | 335 / 16563 (2.0%) | 11321 / 165630 (6.8%) | −167.0 | −164.9 | 0.30 |
| ESR1 SRX20282946 | MCF-7 Breast | 184 / 16563 (1.1%) | 8616 / 165630 (5.2%) | −166.9 | −164.8 | 0.21 |
| WWTR1 SRX10119378 | MCF 10A Breast | 362 / 16563 (2.2%) | 11772 / 165630 (7.1%) | −166.8 | −164.7 | 0.31 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 510 / 16563 (3.1%) | 930 / 165630 (0.6%) | −166.8 | −164.7 | 5.48 |
| ARID1A SRX5089385 | MCF-7 Breast | 231 / 16563 (1.4%) | 9486 / 165630 (5.7%) | −166.6 | −164.4 | 0.24 |
| ESR1 SRX2943589 | MCF-7 Breast | 149 / 16563 (0.9%) | 7909 / 165630 (4.8%) | −166.4 | −164.3 | 0.19 |
| SMARCA4 SRX5212366 | Mel270 Others | 456 / 16563 (2.8%) | 13273 / 165630 (8.0%) | −166.2 | −164.1 | 0.34 |
| TCF12 SRX190356 | SK-N-SH Neural | 962 / 16563 (5.8%) | 20665 / 165630 (12.5%) | −165.9 | −163.8 | 0.47 |
| FOXA1 SRX219284 | LNCAP Prostate | 460 / 16563 (2.8%) | 13324 / 165630 (8.0%) | −165.9 | −163.8 | 0.35 |
| ESR1 SRX3110725 | MCF-7 Breast | 294 / 16563 (1.8%) | 10583 / 165630 (6.4%) | −165.8 | −163.7 | 0.28 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 677 / 16563 (4.1%) | 16615 / 165630 (10.0%) | −165.8 | −163.7 | 0.41 |
| KAT7 DRX234808 | 293 Kidney | 788 / 16563 (4.8%) | 2235 / 165630 (1.3%) | −165.4 | −163.3 | 3.53 |
| JUNB SRX8488089 | SUM 229PE Breast | 336 / 16563 (2.0%) | 11287 / 165630 (6.8%) | −165.4 | −163.3 | 0.30 |
| FOXA1 SRX3923515 | MCF-7 Breast | 166 / 16563 (1.0%) | 8194 / 165630 (4.9%) | −164.5 | −162.5 | 0.20 |
| EP300 SRX1012648 | MCF-7 Breast | 140 / 16563 (0.8%) | 7671 / 165630 (4.6%) | −164.5 | −162.4 | 0.18 |
| FOXA1 SRX5203303 | MCF-7 Breast | 83 / 16563 (0.5%) | 6433 / 165630 (3.9%) | −164.5 | −162.4 | 0.13 |
| ESR1 SRX20282971 | MCF-7 Breast | 334 / 16563 (2.0%) | 11221 / 165630 (6.8%) | −164.4 | −162.3 | 0.30 |
| FOXA1 SRX1961158 | T-47D Breast | 327 / 16563 (2.0%) | 11099 / 165630 (6.7%) | −164.2 | −162.1 | 0.29 |
| JUN SRX17561461 | LPS141 Adipocyte | 511 / 16563 (3.1%) | 14055 / 165630 (8.5%) | −164.0 | −161.9 | 0.36 |
| FOXA1 SRX1961157 | T-47D Breast | 365 / 16563 (2.2%) | 11725 / 165630 (7.1%) | −163.9 | −161.9 | 0.31 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 506 / 16563 (3.1%) | 13966 / 165630 (8.4%) | −163.7 | −161.6 | 0.36 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 352 / 16563 (2.1%) | 11501 / 165630 (6.9%) | −163.7 | −161.6 | 0.31 |
| ESR1 SRX330069 | MCF-7 Breast | 191 / 16563 (1.2%) | 8645 / 165630 (5.2%) | −163.5 | −161.4 | 0.22 |
| ESR1 SRX20282953 | MCF-7 Breast | 273 / 16563 (1.6%) | 10138 / 165630 (6.1%) | −163.2 | −161.2 | 0.27 |
| ARID1A SRX5089391 | MCF-7 Breast | 168 / 16563 (1.0%) | 8190 / 165630 (4.9%) | −163.1 | −161.0 | 0.21 |
| FOXA1 SRX6878603 | LNCAP Prostate | 373 / 16563 (2.3%) | 11826 / 165630 (7.1%) | −162.9 | −160.9 | 0.32 |
| ESR1 SRX10365533 | MCF-7 Breast | 140 / 16563 (0.8%) | 7620 / 165630 (4.6%) | −162.6 | −160.5 | 0.18 |
| NR3C1 SRX10976921 | A549 Lung | 223 / 16563 (1.3%) | 9217 / 165630 (5.6%) | −162.6 | −160.5 | 0.24 |
| FOXA1 SRX3923519 | MCF-7 Breast | 189 / 16563 (1.1%) | 8582 / 165630 (5.2%) | −162.6 | −160.5 | 0.22 |
| ESR1 SRX330070 | MCF-7 Breast | 156 / 16563 (0.9%) | 7940 / 165630 (4.8%) | −162.5 | −160.5 | 0.20 |
| FOXA1 SRX190282 | A549 Lung | 216 / 16563 (1.3%) | 9085 / 165630 (5.5%) | −162.5 | −160.4 | 0.24 |
| ESR1 SRX5323873 | MCF-7 Breast | 421 / 16563 (2.5%) | 12589 / 165630 (7.6%) | −162.5 | −160.4 | 0.33 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 234 / 16563 (1.4%) | 9402 / 165630 (5.7%) | −162.0 | −159.9 | 0.25 |
| CDK9 SRX7366783 | MCF-7 Breast | 252 / 16563 (1.5%) | 134 / 165630 (0.1%) | −161.8 | −159.7 | 18.81 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 252 / 16563 (1.5%) | 9717 / 165630 (5.9%) | −161.7 | −159.6 | 0.26 |
| ARID5B SRX3230377 | Hep G2 Liver | 895 / 16563 (5.4%) | 19560 / 165630 (11.8%) | −161.5 | −159.4 | 0.46 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 291 / 16563 (1.8%) | 10392 / 165630 (6.3%) | −161.4 | −159.4 | 0.28 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1854 / 16563 (11.2%) | 9006 / 165630 (5.4%) | −161.3 | −159.3 | 2.06 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 197 / 16563 (1.2%) | 8696 / 165630 (5.3%) | −161.3 | −159.2 | 0.23 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 293 / 16563 (1.8%) | 10411 / 165630 (6.3%) | −160.9 | −158.9 | 0.28 |
| STAT3 SRX150630 | MCF 10A Breast | 314 / 16563 (1.9%) | 10771 / 165630 (6.5%) | −160.9 | −158.8 | 0.29 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1522 / 16563 (9.2%) | 6738 / 165630 (4.1%) | −160.6 | −158.6 | 2.26 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 290 / 16563 (1.8%) | 10341 / 165630 (6.2%) | −160.3 | −158.2 | 0.28 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 213 / 16563 (1.3%) | 8962 / 165630 (5.4%) | −160.1 | −158.1 | 0.24 |
| ESR1 SRX1012632 | MCF-7 Breast | 150 / 16563 (0.9%) | 7742 / 165630 (4.7%) | −160.0 | −157.9 | 0.19 |
| STAT3 SRX150479 | MCF 10A Breast | 318 / 16563 (1.9%) | 10804 / 165630 (6.5%) | −159.9 | −157.8 | 0.29 |
| ARID1A SRX5089388 | MCF-7 Breast | 152 / 16563 (0.9%) | 7778 / 165630 (4.7%) | −159.7 | −157.7 | 0.20 |
| SMARCA4 SRX5212362 | Mel270 Others | 614 / 16563 (3.7%) | 15462 / 165630 (9.3%) | −159.7 | −157.7 | 0.40 |
| JUNB SRX10119386 | MCF 10A Breast | 307 / 16563 (1.9%) | 10610 / 165630 (6.4%) | −159.7 | −157.6 | 0.29 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 152 / 16563 (0.9%) | 7754 / 165630 (4.7%) | −159.0 | −156.9 | 0.20 |
| ESR1 SRX8537723 | MCF-7 Breast | 267 / 16563 (1.6%) | 9878 / 165630 (6.0%) | −158.4 | −156.4 | 0.27 |
| FOXA1 SRX3931056 | MCF-7 Breast | 183 / 16563 (1.1%) | 8344 / 165630 (5.0%) | −158.4 | −156.3 | 0.22 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 321 / 16563 (1.9%) | 10807 / 165630 (6.5%) | −158.4 | −156.3 | 0.30 |
| MECOM SRX23677885 | HNT-34 Blood | 1693 / 16563 (10.2%) | 7949 / 165630 (4.8%) | −158.3 | −156.3 | 2.13 |
| STAT5B SRX831881 | CD8+ T cells Blood | 254 / 16563 (1.5%) | 147 / 165630 (0.1%) | −158.2 | −156.2 | 17.28 |
| ARID1A SRX5089382 | MCF-7 Breast | 226 / 16563 (1.4%) | 9140 / 165630 (5.5%) | −158.2 | −156.2 | 0.25 |
| ESR1 SRX1012629 | MCF-7 Breast | 204 / 16563 (1.2%) | 8718 / 165630 (5.3%) | −157.7 | −155.6 | 0.23 |
| ESR1 SRX10365558 | MCF-7 Breast | 225 / 16563 (1.4%) | 9099 / 165630 (5.5%) | −157.5 | −155.5 | 0.25 |
| ESR1 SRX20282938 | MCF-7 Breast | 277 / 16563 (1.7%) | 10026 / 165630 (6.1%) | −157.5 | −155.5 | 0.28 |
| AR SRX9109110 | MDA-MB-453 Breast | 683 / 16563 (4.1%) | 16392 / 165630 (9.9%) | −157.5 | −155.5 | 0.42 |
| SSRP1 SRX3436567 | HT-1080 Bone | 395 / 16563 (2.4%) | 554 / 165630 (0.3%) | −157.3 | −155.3 | 7.13 |
| FOXA1 SRX5323830 | T-47D Breast | 188 / 16563 (1.1%) | 8404 / 165630 (5.1%) | −157.3 | −155.3 | 0.22 |
| STAT3 SRX150536 | MCF 10A Breast | 394 / 16563 (2.4%) | 11949 / 165630 (7.2%) | −156.5 | −154.5 | 0.33 |
| ESR1 SRX20282959 | MCF-7 Breast | 127 / 16563 (0.8%) | 7171 / 165630 (4.3%) | −156.3 | −154.3 | 0.18 |
| ESR1 SRX1531796 | MCF-7 Breast | 170 / 16563 (1.0%) | 8018 / 165630 (4.8%) | −155.9 | −153.9 | 0.21 |
| MECOM SRX23677884 | HNT-34 Blood | 1660 / 16563 (10.0%) | 7776 / 165630 (4.7%) | −155.9 | −153.9 | 2.13 |
| JUNB SRX8488074 | SUM 229PE Breast | 475 / 16563 (2.9%) | 13212 / 165630 (8.0%) | −155.9 | −153.9 | 0.36 |
| RUNX1 SRX2014504 | Jurkat Blood | 2316 / 16563 (14.0%) | 12515 / 165630 (7.6%) | −155.8 | −153.8 | 1.85 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 215 / 16563 (1.3%) | 8859 / 165630 (5.3%) | −155.7 | −153.6 | 0.24 |
| CDK9 SRX7366781 | MCF-7 Breast | 239 / 16563 (1.4%) | 122 / 165630 (0.1%) | −155.6 | −153.6 | 19.59 |
| FOXL2 SRX6957431 | KGN Gonad | 834 / 16563 (5.0%) | 18467 / 165630 (11.1%) | −155.5 | −153.5 | 0.45 |
| NKX2-1 SRX2164786 | A549 Lung | 599 / 16563 (3.6%) | 15077 / 165630 (9.1%) | −155.4 | −153.4 | 0.40 |
| JUND SRX150408 | HeLa Uterus | 309 / 16563 (1.9%) | 10505 / 165630 (6.3%) | −155.3 | −153.3 | 0.29 |
| FOXA1 SRX1447316 | MCF-7 Breast | 131 / 16563 (0.8%) | 7218 / 165630 (4.4%) | −155.1 | −153.1 | 0.18 |
| NANOG SRX10445309 | Neural crest cells Neural | 182 / 16563 (1.1%) | 8226 / 165630 (5.0%) | −155.1 | −153.1 | 0.22 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 250 / 16563 (1.5%) | 9473 / 165630 (5.7%) | −155.0 | −153.0 | 0.26 |
| VGLL1 SRX18013277 | FULVR Breast | 130 / 16563 (0.8%) | 7192 / 165630 (4.3%) | −155.0 | −153.0 | 0.18 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 185 / 16563 (1.1%) | 8271 / 165630 (5.0%) | −154.7 | −152.7 | 0.22 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 534 / 16563 (3.2%) | 1118 / 165630 (0.7%) | −154.6 | −152.6 | 4.78 |
| SOX13 SRX2636248 | Hep G2 Liver | 489 / 16563 (3.0%) | 13383 / 165630 (8.1%) | −154.6 | −152.6 | 0.37 |
| GATA3 SRX5457550 | MCF-7 Breast | 407 / 16563 (2.5%) | 12096 / 165630 (7.3%) | −154.6 | −152.6 | 0.34 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 654 / 16563 (3.9%) | 1674 / 165630 (1.0%) | −154.5 | −152.5 | 3.91 |
| FOXA1 SRX5323845 | MCF-7 Breast | 106 / 16563 (0.6%) | 6670 / 165630 (4.0%) | −154.3 | −152.3 | 0.16 |
| NCOA3 SRX4663589 | MCF-7 Breast | 73 / 16563 (0.4%) | 5923 / 165630 (3.6%) | −154.2 | −152.2 | 0.12 |
| JUNB SRX4192882 | MCF 10A Breast | 279 / 16563 (1.7%) | 9951 / 165630 (6.0%) | −154.1 | −152.1 | 0.28 |
| ESR1 SRX1469949 | MCF-7 Breast | 189 / 16563 (1.1%) | 8328 / 165630 (5.0%) | −154.0 | −152.0 | 0.23 |
| ESR1 SRX3123829 | MCF-7 Breast | 190 / 16563 (1.1%) | 8338 / 165630 (5.0%) | −153.8 | −151.8 | 0.23 |
| FOXA1 SRX9604647 | LNCAP Prostate | 544 / 16563 (3.3%) | 14180 / 165630 (8.6%) | −153.5 | −151.5 | 0.38 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 335 / 16563 (2.0%) | 10871 / 165630 (6.6%) | −153.2 | −151.2 | 0.31 |
| ESR1 SRX5323872 | MCF-7 Breast | 350 / 16563 (2.1%) | 11117 / 165630 (6.7%) | −153.1 | −151.2 | 0.31 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 109 / 16563 (0.7%) | 6701 / 165630 (4.0%) | −153.1 | −151.2 | 0.16 |
| FOXA1 SRX3931032 | MCF-7 Breast | 189 / 16563 (1.1%) | 8293 / 165630 (5.0%) | −153.0 | −151.0 | 0.23 |
| ESR1 SRX5323871 | MCF-7 Breast | 385 / 16563 (2.3%) | 11683 / 165630 (7.1%) | −152.9 | −150.9 | 0.33 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 511 / 16563 (3.1%) | 13654 / 165630 (8.2%) | −152.8 | −150.8 | 0.37 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 284 / 16563 (1.7%) | 9993 / 165630 (6.0%) | −152.7 | −150.8 | 0.28 |
| ZEB1 SRX13298925 | MCF-7 Breast | 205 / 16563 (1.2%) | 8581 / 165630 (5.2%) | −152.6 | −150.6 | 0.24 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 858 / 16563 (5.2%) | 2765 / 165630 (1.7%) | −152.5 | −150.5 | 3.10 |
| AR SRX1067068 | LHSAR Prostate | 428 / 16563 (2.6%) | 12355 / 165630 (7.5%) | −152.5 | −150.5 | 0.35 |
| SMARCA4 SRX5212357 | Mel270 Others | 523 / 16563 (3.2%) | 13823 / 165630 (8.3%) | −152.4 | −150.4 | 0.38 |
| HMG20A SRX2630163 | Hep G2 Liver | 187 / 16563 (1.1%) | 8241 / 165630 (5.0%) | −152.4 | −150.4 | 0.23 |
| PROX1 SRX3230397 | Hep G2 Liver | 251 / 16563 (1.5%) | 9402 / 165630 (5.7%) | −152.3 | −150.3 | 0.27 |
| FOXA1 SRX1161205 | T-47D Breast | 174 / 16563 (1.1%) | 7987 / 165630 (4.8%) | −152.2 | −150.2 | 0.22 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 361 / 16563 (2.2%) | 11266 / 165630 (6.8%) | −152.1 | −150.1 | 0.32 |
| FOXA1 SRX9604645 | LNCAP Prostate | 506 / 16563 (3.1%) | 13546 / 165630 (8.2%) | −151.8 | −149.9 | 0.37 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1050 / 16563 (6.3%) | 21269 / 165630 (12.8%) | −151.7 | −149.7 | 0.49 |
| ESR1 SRX2912055 | MCF-7 Breast | 119 / 16563 (0.7%) | 6869 / 165630 (4.1%) | −151.6 | −149.6 | 0.17 |
| FOXA1 SRX2017929 | LNCAP Prostate | 475 / 16563 (2.9%) | 13060 / 165630 (7.9%) | −151.6 | −149.6 | 0.36 |
| ARID5B SRX10475139 | Hep G2 Liver | 391 / 16563 (2.4%) | 11731 / 165630 (7.1%) | −151.6 | −149.6 | 0.33 |
| NR3C1 SRX19024866 | MCF-7 Breast | 104 / 16563 (0.6%) | 6550 / 165630 (4.0%) | −151.5 | −149.6 | 0.16 |
| EP300 SRX2194265 | SUM 159PT Breast | 575 / 16563 (3.5%) | 14559 / 165630 (8.8%) | −151.1 | −149.1 | 0.39 |
| GATA3 SRX100559 | T-47D Breast | 405 / 16563 (2.4%) | 11942 / 165630 (7.2%) | −151.1 | −149.1 | 0.34 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 311 / 16563 (1.9%) | 10389 / 165630 (6.3%) | −150.8 | −148.9 | 0.30 |
| NFYB SRX16608147 | HeLa Uterus | 261 / 16563 (1.6%) | 183 / 165630 (0.1%) | −150.8 | −148.8 | 14.26 |
| FOXA1 SRX1161207 | T-47D Breast | 128 / 16563 (0.8%) | 7024 / 165630 (4.2%) | −150.5 | −148.6 | 0.18 |
| FOXA1 SRX5323846 | MCF-7 Breast | 114 / 16563 (0.7%) | 6721 / 165630 (4.1%) | −149.9 | −148.0 | 0.17 |
| GATAD2A SRX2636506 | Hep G2 Liver | 475 / 16563 (2.9%) | 12984 / 165630 (7.8%) | −149.5 | −147.5 | 0.37 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 642 / 16563 (3.9%) | 15486 / 165630 (9.3%) | −149.3 | −147.4 | 0.41 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 376 / 16563 (2.3%) | 11412 / 165630 (6.9%) | −149.3 | −147.3 | 0.33 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 300 / 16563 (1.8%) | 10151 / 165630 (6.1%) | −149.2 | −147.2 | 0.30 |
| ESR1 SRX4451212 | MCF-7 Breast | 339 / 16563 (2.0%) | 10800 / 165630 (6.5%) | −149.0 | −147.1 | 0.31 |
| MethylCap SRX014767 | NB-4 Blood | 1652 / 16563 (10.0%) | 7884 / 165630 (4.8%) | −148.7 | −146.8 | 2.10 |
| ESR1 SRX5323878 | MCF-7 Breast | 359 / 16563 (2.2%) | 11108 / 165630 (6.7%) | −148.5 | −146.6 | 0.32 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 786 / 16563 (4.7%) | 2420 / 165630 (1.5%) | −148.5 | −146.5 | 3.25 |
| Epitope tags SRX2255894 | 293 Kidney | 1301 / 16563 (7.9%) | 5523 / 165630 (3.3%) | −148.3 | −146.4 | 2.36 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 847 / 16563 (5.1%) | 18359 / 165630 (11.1%) | −148.3 | −146.3 | 0.46 |
| FOXA1 SRX5203307 | MCF-7 Breast | 84 / 16563 (0.5%) | 6017 / 165630 (3.6%) | −148.2 | −146.3 | 0.14 |
| CEBPB SRX2194250 | SUM 159PT Breast | 454 / 16563 (2.7%) | 12611 / 165630 (7.6%) | −148.2 | −146.2 | 0.36 |
| NR3C1 SRX17639413 | A549 Lung | 241 / 16563 (1.5%) | 9095 / 165630 (5.5%) | −148.1 | −146.2 | 0.26 |
| FOXA1 SRX2642368 | VCaP Prostate | 444 / 16563 (2.7%) | 12455 / 165630 (7.5%) | −148.1 | −146.2 | 0.36 |
| EP300 SRX1012644 | MCF-7 Breast | 149 / 16563 (0.9%) | 7380 / 165630 (4.5%) | −148.1 | −146.2 | 0.20 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1972 / 16563 (11.9%) | 10191 / 165630 (6.2%) | −147.7 | −145.7 | 1.94 |
| ESR1 SRX2513517 | MCF-7 Breast | 237 / 16563 (1.4%) | 9007 / 165630 (5.4%) | −147.6 | −145.7 | 0.26 |
| AR SRX9109113 | MDA-MB-453 Breast | 720 / 16563 (4.3%) | 16541 / 165630 (10.0%) | −147.6 | −145.6 | 0.44 |
| EP300 SRX717859 | HeLa Uterus | 180 / 16563 (1.1%) | 7959 / 165630 (4.8%) | −147.5 | −145.6 | 0.23 |
| ESR1 SRX792933 | LY2 Breast | 292 / 16563 (1.8%) | 9954 / 165630 (6.0%) | −147.3 | −145.4 | 0.29 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1320 / 16563 (8.0%) | 24626 / 165630 (14.9%) | −147.3 | −145.3 | 0.54 |
| YAP1 SRX10119364 | MCF 10A Breast | 303 / 16563 (1.8%) | 10138 / 165630 (6.1%) | −147.2 | −145.3 | 0.30 |
| JUN SRX883584 | MDA-MB-231 Breast | 581 / 16563 (3.5%) | 14502 / 165630 (8.8%) | −147.1 | −145.2 | 0.40 |
| GATAD2A SRX2636507 | Hep G2 Liver | 398 / 16563 (2.4%) | 11683 / 165630 (7.1%) | −146.9 | −145.0 | 0.34 |
| MECOM SRX23677896 | HNT-34 Blood | 1997 / 16563 (12.1%) | 10400 / 165630 (6.3%) | −146.8 | −144.9 | 1.92 |
| FOXA1 SRX15431000 | T-47D Breast | 292 / 16563 (1.8%) | 9934 / 165630 (6.0%) | −146.7 | −144.8 | 0.29 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1182 / 16563 (7.1%) | 4790 / 165630 (2.9%) | −146.6 | −144.7 | 2.47 |
| SMARCA4 SRX5212371 | Mel270 Others | 528 / 16563 (3.2%) | 13672 / 165630 (8.3%) | −146.2 | −144.3 | 0.39 |
| FOXA1 SRX1787654 | MCF-7 Breast | 117 / 16563 (0.7%) | 6669 / 165630 (4.0%) | −146.0 | −144.1 | 0.18 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 87 / 16563 (0.5%) | 6017 / 165630 (3.6%) | −145.9 | −143.9 | 0.14 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 712 / 16563 (4.3%) | 2060 / 165630 (1.2%) | −145.6 | −143.7 | 3.46 |
| NR3C1 SRX18884271 | A549 Lung | 180 / 16563 (1.1%) | 7900 / 165630 (4.8%) | −145.6 | −143.6 | 0.23 |
| NR3C1 SRX10977357 | A549 Lung | 215 / 16563 (1.3%) | 8548 / 165630 (5.2%) | −145.5 | −143.6 | 0.25 |
| FOXA1 SRX5203294 | MCF-7 Breast | 85 / 16563 (0.5%) | 5956 / 165630 (3.6%) | −145.3 | −143.4 | 0.14 |
| CEBPB SRX190345 | MCF-7 Breast | 290 / 16563 (1.8%) | 9853 / 165630 (5.9%) | −145.2 | −143.3 | 0.29 |
| ESR1 SRX1469951 | MCF-7 Breast | 180 / 16563 (1.1%) | 7888 / 165630 (4.8%) | −145.1 | −143.2 | 0.23 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 394 / 16563 (2.4%) | 11546 / 165630 (7.0%) | −144.7 | −142.8 | 0.34 |
| NR3C1 SRX10977372 | A549 Lung | 201 / 16563 (1.2%) | 8267 / 165630 (5.0%) | −144.7 | −142.8 | 0.24 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 277 / 16563 (1.7%) | 9612 / 165630 (5.8%) | −144.7 | −142.8 | 0.29 |
| TP53 SRX19538272 | U2OS Bone | 523 / 16563 (3.2%) | 1151 / 165630 (0.7%) | −144.4 | −142.5 | 4.54 |
| JADE3 DRX300415 | 293 Kidney | 1442 / 16563 (8.7%) | 6538 / 165630 (3.9%) | −144.4 | −142.5 | 2.21 |
| FOXA1 SRX2017928 | LNCAP Prostate | 430 / 16563 (2.6%) | 12095 / 165630 (7.3%) | −144.3 | −142.3 | 0.36 |
| MECOM SRX23677897 | HNT-34 Blood | 1927 / 16563 (11.6%) | 9957 / 165630 (6.0%) | −144.2 | −142.3 | 1.94 |
| NR3C1 SRX8520802 | HCC1187 Breast | 270 / 16563 (1.6%) | 9477 / 165630 (5.7%) | −144.2 | −142.3 | 0.28 |
| EP300 SRX1012643 | MCF-7 Breast | 121 / 16563 (0.7%) | 6703 / 165630 (4.0%) | −144.2 | −142.3 | 0.18 |
| FOXA1 SRX10306473 | T-47D Breast | 138 / 16563 (0.8%) | 7045 / 165630 (4.3%) | −144.1 | −142.2 | 0.20 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 445 / 16563 (2.7%) | 12325 / 165630 (7.4%) | −144.0 | −142.1 | 0.36 |
| ESR1 SRX5323877 | MCF-7 Breast | 284 / 16563 (1.7%) | 9706 / 165630 (5.9%) | −143.9 | −142.0 | 0.29 |
| EP300 SRX10976215 | A549 Lung | 336 / 16563 (2.0%) | 10572 / 165630 (6.4%) | −143.8 | −141.9 | 0.32 |
| TFAP2C SRX018833 | MCF-7 Breast | 340 / 16563 (2.1%) | 10632 / 165630 (6.4%) | −143.6 | −141.7 | 0.32 |
| JUNB SRX10119383 | MCF 10A Breast | 249 / 16563 (1.5%) | 9092 / 165630 (5.5%) | −143.5 | −141.6 | 0.27 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1784 / 16563 (10.8%) | 8943 / 165630 (5.4%) | −143.4 | −141.5 | 1.99 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 290 / 16563 (1.8%) | 284 / 165630 (0.2%) | −143.2 | −141.3 | 10.21 |
| ESR1 SRX11120903 | MCF-7 Breast | 323 / 16563 (2.0%) | 10337 / 165630 (6.2%) | −143.2 | −141.3 | 0.31 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 350 / 16563 (2.1%) | 10779 / 165630 (6.5%) | −143.1 | −141.2 | 0.32 |
| RBFOX2 SRX4708082 | K-562 Blood | 2228 / 16563 (13.5%) | 12229 / 165630 (7.4%) | −142.9 | −141.0 | 1.82 |
| TFAP2C SRX128099 | MCF-7 Breast | 341 / 16563 (2.1%) | 10622 / 165630 (6.4%) | −142.9 | −141.0 | 0.32 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 242 / 16563 (1.5%) | 8948 / 165630 (5.4%) | −142.8 | −140.9 | 0.27 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1277 / 16563 (7.7%) | 5471 / 165630 (3.3%) | −142.8 | −140.9 | 2.33 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 227 / 16563 (1.4%) | 8677 / 165630 (5.2%) | −142.8 | −140.9 | 0.26 |
| ESR1 SRX330068 | MCF-7 Breast | 167 / 16563 (1.0%) | 7564 / 165630 (4.6%) | −142.4 | −140.6 | 0.22 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 242 / 16563 (1.5%) | 8932 / 165630 (5.4%) | −142.4 | −140.5 | 0.27 |
| ESR1 SRX2513520 | MCF-7 Breast | 226 / 16563 (1.4%) | 8647 / 165630 (5.2%) | −142.4 | −140.5 | 0.26 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 348 / 16563 (2.1%) | 10721 / 165630 (6.5%) | −142.3 | −140.5 | 0.32 |
| FOXA1 SRX15391842 | T-47D Breast | 197 / 16563 (1.2%) | 8118 / 165630 (4.9%) | −142.3 | −140.4 | 0.24 |
| PRRX1 SRX15235713 | Hs 578T Breast | 463 / 16563 (2.8%) | 12537 / 165630 (7.6%) | −142.3 | −140.4 | 0.37 |
| ZEB1 SRX13298923 | MCF-7 Breast | 143 / 16563 (0.9%) | 7087 / 165630 (4.3%) | −142.1 | −140.2 | 0.20 |
| FOXA1 SRX6860635 | T-47D Breast | 278 / 16563 (1.7%) | 9545 / 165630 (5.8%) | −142.1 | −140.2 | 0.29 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 731 / 16563 (4.4%) | 2203 / 165630 (1.3%) | −141.9 | −140.0 | 3.32 |
| NR3C1 SRX19024870 | MCF-7 Breast | 111 / 16563 (0.7%) | 6421 / 165630 (3.9%) | −141.7 | −139.8 | 0.17 |
| ESR1 SRX10365534 | MCF-7 Breast | 95 / 16563 (0.6%) | 6082 / 165630 (3.7%) | −141.7 | −139.8 | 0.16 |
| FOXA1 SRX9604646 | LNCAP Prostate | 512 / 16563 (3.1%) | 13260 / 165630 (8.0%) | −141.6 | −139.7 | 0.39 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 91 / 16563 (0.5%) | 5990 / 165630 (3.6%) | −141.6 | −139.7 | 0.15 |
| DAXX SRX1021630 | PC-3 Prostate | 381 / 16563 (2.3%) | 11229 / 165630 (6.8%) | −141.6 | −139.7 | 0.34 |
| FOXA1 SRX219285 | LNCAP Prostate | 344 / 16563 (2.1%) | 10626 / 165630 (6.4%) | −141.4 | −139.6 | 0.32 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1680 / 16563 (10.1%) | 8254 / 165630 (5.0%) | −141.3 | −139.5 | 2.04 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 363 / 16563 (2.2%) | 10931 / 165630 (6.6%) | −141.3 | −139.4 | 0.33 |
| NR3C1 SRX18884260 | A549 Lung | 207 / 16563 (1.2%) | 8270 / 165630 (5.0%) | −141.3 | −139.4 | 0.25 |
| FOXA2 SRX10475773 | Hep G2 Liver | 462 / 16563 (2.8%) | 12480 / 165630 (7.5%) | −141.1 | −139.2 | 0.37 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 105 / 16563 (0.6%) | 6274 / 165630 (3.8%) | −141.0 | −139.1 | 0.17 |
| GFP SRX6949256 | HeLa Uterus | 423 / 16563 (2.6%) | 11864 / 165630 (7.2%) | −140.8 | −138.9 | 0.36 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 739 / 16563 (4.5%) | 16539 / 165630 (10.0%) | −140.8 | −138.9 | 0.45 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 137 / 16563 (0.8%) | 6922 / 165630 (4.2%) | −140.6 | −138.8 | 0.20 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 124 / 16563 (0.7%) | 6656 / 165630 (4.0%) | −140.5 | −138.7 | 0.19 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 671 / 16563 (4.1%) | 15559 / 165630 (9.4%) | −140.4 | −138.6 | 0.43 |
| EP300 SRX176883 | MCF-7 Breast | 166 / 16563 (1.0%) | 7481 / 165630 (4.5%) | −140.4 | −138.6 | 0.22 |
| MethylCap SRX014766 | NB-4 Blood | 1488 / 16563 (9.0%) | 6939 / 165630 (4.2%) | −140.3 | −138.5 | 2.14 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 741 / 16563 (4.5%) | 16550 / 165630 (10.0%) | −140.3 | −138.5 | 0.45 |
| FOS SRX3322636 | MCF-7 Breast | 240 / 16563 (1.4%) | 8827 / 165630 (5.3%) | −140.2 | −138.3 | 0.27 |
| BMI1 SRX644729 | 293 Kidney | 228 / 16563 (1.4%) | 137 / 165630 (0.1%) | −140.1 | −138.2 | 16.64 |
| CEBPA SRX4705113 | MOLM-13 Blood | 885 / 16563 (5.3%) | 18540 / 165630 (11.2%) | −140.0 | −138.2 | 0.48 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 958 / 16563 (5.8%) | 19526 / 165630 (11.8%) | −139.9 | −138.1 | 0.49 |
| FOXA1 SRX3923511 | MCF-7 Breast | 131 / 16563 (0.8%) | 6785 / 165630 (4.1%) | −139.9 | −138.1 | 0.19 |
| ESR1 SRX2513521 | MCF-7 Breast | 169 / 16563 (1.0%) | 7524 / 165630 (4.5%) | −139.8 | −138.0 | 0.22 |
| ESR1 SRX1012633 | MCF-7 Breast | 188 / 16563 (1.1%) | 7875 / 165630 (4.8%) | −139.8 | −138.0 | 0.24 |
| FOXA1 SRX497612 | VCaP Prostate | 361 / 16563 (2.2%) | 10840 / 165630 (6.5%) | −139.7 | −137.9 | 0.33 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 569 / 16563 (3.4%) | 14040 / 165630 (8.5%) | −139.6 | −137.8 | 0.41 |
| EP300 SRX100544 | Hep G2 Liver | 282 / 16563 (1.7%) | 9530 / 165630 (5.8%) | −139.5 | −137.7 | 0.30 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1669 / 16563 (10.1%) | 8232 / 165630 (5.0%) | −139.1 | −137.2 | 2.03 |
| FOXA1 SRX10468635 | Breast cancer cells Breast | 310 / 16563 (1.9%) | 9983 / 165630 (6.0%) | −139.0 | −137.2 | 0.31 |
| AR SRX15946405 | MDA-MB-453 Breast | 236 / 16563 (1.4%) | 8710 / 165630 (5.3%) | −138.8 | −136.9 | 0.27 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 184 / 16563 (1.1%) | 7770 / 165630 (4.7%) | −138.8 | −136.9 | 0.24 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 744 / 16563 (4.5%) | 16517 / 165630 (10.0%) | −138.5 | −136.7 | 0.45 |
| NFIL3 SRX2630334 | Hep G2 Liver | 304 / 16563 (1.8%) | 9860 / 165630 (6.0%) | −138.3 | −136.5 | 0.31 |
| ZEB1 SRX13298924 | MCF-7 Breast | 173 / 16563 (1.0%) | 7550 / 165630 (4.6%) | −138.3 | −136.5 | 0.23 |
| AR SRX11149848 | MDA-MB-453 Breast | 237 / 16563 (1.4%) | 8715 / 165630 (5.3%) | −138.3 | −136.5 | 0.27 |
| EP300 ERX626821 | U-937 Blood | 1156 / 16563 (7.0%) | 4774 / 165630 (2.9%) | −138.3 | −136.4 | 2.42 |
| NR3C1 SRX10977373 | A549 Lung | 197 / 16563 (1.2%) | 7993 / 165630 (4.8%) | −138.1 | −136.3 | 0.25 |
| FOXA1 SRX3931073 | MCF-7 Breast | 217 / 16563 (1.3%) | 8350 / 165630 (5.0%) | −138.1 | −136.2 | 0.26 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 343 / 16563 (2.1%) | 10485 / 165630 (6.3%) | −137.9 | −136.0 | 0.33 |
| FOXA1 SRX2642366 | VCaP Prostate | 371 / 16563 (2.2%) | 10937 / 165630 (6.6%) | −137.9 | −136.0 | 0.34 |
| ESR1 SRX1995229 | MCF-7 Breast | 380 / 16563 (2.3%) | 11082 / 165630 (6.7%) | −137.8 | −135.9 | 0.34 |
| FOXA1 SRX1885184 | LNCAP Prostate | 352 / 16563 (2.1%) | 10629 / 165630 (6.4%) | −137.8 | −135.9 | 0.33 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1007 / 16563 (6.1%) | 3851 / 165630 (2.3%) | −137.7 | −135.9 | 2.61 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1103 / 16563 (6.7%) | 21366 / 165630 (12.9%) | −137.7 | −135.8 | 0.52 |
| FOXA1 SRX497613 | VCaP Prostate | 271 / 16563 (1.6%) | 9270 / 165630 (5.6%) | −137.3 | −135.5 | 0.29 |
| SOX5 SRX2636544 | Hep G2 Liver | 379 / 16563 (2.3%) | 11045 / 165630 (6.7%) | −137.3 | −135.4 | 0.34 |
| ESR1 SRX5534831 | MCF-7 Breast | 292 / 16563 (1.8%) | 9623 / 165630 (5.8%) | −137.3 | −135.4 | 0.30 |
| FOXA1 SRX6878604 | LNCAP Prostate | 303 / 16563 (1.8%) | 9806 / 165630 (5.9%) | −137.3 | −135.4 | 0.31 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 231 / 16563 (1.4%) | 8572 / 165630 (5.2%) | −137.2 | −135.3 | 0.27 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 261 / 16563 (1.6%) | 9091 / 165630 (5.5%) | −137.1 | −135.3 | 0.29 |
| FOXA1 SRX3931031 | MCF-7 Breast | 171 / 16563 (1.0%) | 7469 / 165630 (4.5%) | −136.8 | −135.0 | 0.23 |
| KAT7 DRX300414 | 293 Kidney | 597 / 16563 (3.6%) | 1570 / 165630 (0.9%) | −136.6 | −134.8 | 3.80 |
| Epitope tags SRX2745846 | MCF 10A Breast | 249 / 16563 (1.5%) | 8864 / 165630 (5.4%) | −136.5 | −134.6 | 0.28 |
| FOXA2 SRX11650941 | hESC derived pancreatic cells Pluripotent stem cell | 186 / 16563 (1.1%) | 7735 / 165630 (4.7%) | −136.4 | −134.6 | 0.24 |
| FOXA1 SRX497611 | VCaP Prostate | 289 / 16563 (1.7%) | 9544 / 165630 (5.8%) | −136.4 | −134.5 | 0.30 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1689 / 16563 (10.2%) | 8446 / 165630 (5.1%) | −136.1 | −134.3 | 2.00 |
| MAU2 SRX11120892 | MCF-7 Breast | 146 / 16563 (0.9%) | 6963 / 165630 (4.2%) | −136.0 | −134.1 | 0.21 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 244 / 16563 (1.5%) | 8763 / 165630 (5.3%) | −136.0 | −134.1 | 0.28 |
| AR SRX9469987 | LAPC-4 Prostate | 171 / 16563 (1.0%) | 7440 / 165630 (4.5%) | −135.9 | −134.1 | 0.23 |
| FOXA1 SRX1885181 | LNCAP Prostate | 346 / 16563 (2.1%) | 10471 / 165630 (6.3%) | −135.9 | −134.1 | 0.33 |
Showing first 500 of 22921 rows.